Pancreatic cancer concomitant with other malignancies – single centre experience

Abstract

Introduction. Pancreatic cancer (PC) remains one of the most deadly tumours. The study aimed to describe a single--centre experience of PC concomitant with other malignancies. Material and methods. Fifteen cases of PC associated with other primary malignancies were selected from the studied cohort. Statistical analysis with the usage of appropriate tests was conducted. Results. Patients were presented with PC and other malignancies, encompassing breast, ovarian, colorectal, prostate, hepatocellular carcinomas, and thymoma. The median survival time was 75.0 months from the diagnosis of the first primary cancer and 14.0 months from the second primary cancer diagnosis. There was no significant difference in progression-free survival (p = 0.44) and overall survival (p = 0.28) between patients with and without a history of other malignancies. Conclusions. The long-term follow-up examinations for oncological patients may allow the early diagnosis of concomitant malignancies. Nevertheless, results suggest that second primary tumours do not affect patients overall survival.